1Chen H H, Zhou H J, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro [J] . Pharm acol Res, 2003, 48 (3): 231 - 236.
2Yamachika E, Habte T,Oda D,et al.Artemisinin: an alternative treatment for oral squamous cell carcinoma [ J ]. Anticancer Res, 2004, 24 (4):2153 - 2160.
3Singh N P, Lai H C. Artemisinin induces apoptosis in human cancer cells[J]. Anticancer Res, 2004, 24 (4):2277 - 2280.
4Disbrow G L,Baege A C, Kierp ice K A, et al . Dihydroartemisinin is cytotoxic to papillomavirus- expressing epithelial cells in vitro and invivo[J]. Cancer Res, 2005, 65 (23) : 10854 - 10861.
8Singh N P, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin [ J ]. Life Sci, 2001,70 ( 1 ) : 49 - 56.
9Efferth T. Willmar Schwabe Award 2006:Anti- plasmodial and antitumor activity of artemisinin from bench to bedside [ J ] . Planta Med, 2007, 73 (4) :299 - 309.
7Posner GH, Paik IH, Sur S, et al. Orally active, antimalarial, anticancer,artemisinin-derived trioxane dimmers with high stability and efficacy. J Med Chem 2003;46(6):1060-5
8Singh NP, Lai H.Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 2001;70(1):49-56
9Posner GH, Northrop J, Paik IH,et al. New chemical and biological aspects of artemisinin-derived trioxane dimers.Bioorg Med Chem 2002;10(1):227-32
10Galal AM,Ross SA,ElSohly MA, et al. Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation.J Nat Prod 2002;65(2):184-8
